Список литературы
Заславский Д.В., Баринова А.Н., Плавинский С.Л. Синдром отмены топических кортикостероидов: симптомы, признаки и подходы к лечению // Практика педиатра. 2022. № 3. С. 27–34.
Кубанов А.А., Намазова-Баранова Л.С., Хаитов Р.М. и др. Атопический дерматит // Российский аллергологический журнал. 2021. Т. 18. № 3. С. 44–92. DOI: https://doi.org/10.36691/RJA1474. eLIBRARY ID: 46864789.
Левашова С.В. Нарушения регуляции эпидермального барьера в формировании атопического дерматита и бронхиальной астмы у детей: дис. ... канд. мед. наук. Уфа, 2015. 156 с. URL: https://sechenov.ru/upload/444113.pdf (дата обращения: 24.08.2021).
Макарова С.Г. Факторы, определяющие предрасположенность к пищевой аллергии // DNA Health. 2018. № 6. С. 31–33.
Abuabara K., Yu A.M., Okhovat J.P. et al. The prevalence of atopic dermatitis beyond childhood: a systematic review and meta-analysis of longitudinal studies // Allergy. 2017. Vol. 73. P. 696–704.
Addor F.A.S., Aoki V. Skin barrier in atopic dermatitis // An. Bras. Dermatol. 2010. Vol. 85. N. 2. P. 184–194.
Agrawal R., Woodfolk J.A. Skin barrier defects in atopic dermatitis // Curr. Allergy Asthma Rep. 2014. Vol. 14. N. 5. P. 433.
Akerström U., Reitamo S., Langeland T. et al. Comparison of moisturizing creams for the prevention of atopic dermatitis relapse: a randomized double-blind controlled multicentre clinical trial // Acta Derm. Venereol. 2015. Vol. 95. N. 5. P. 587–592.
Akiyama M. FLG mutations in ichthyosis vulgaris and atopic eczema: Spectrum of mutations and population genetics // Br. J. Dermatol. 2009. Vol. 162. P. 472–477.
Ali Z., Suppli U.C., Agner T., Thomsen S.F. Is atopic dermatitis associated with obesity? A systematic review of observational studies // J. Eur. Acad. Dermatol. Venereol. 2018. Vol. 32. N. 8. P. 1246–1255.
Ashkenazi-Hoffnung L., Bilavsky E., Amir J. Acrodermatitis enteropathica in a 9-month-old infant // Isr. Med. Assoc. J. 2011. Vol. 13. N. 4. P. 258.
Bager P., Wohlfahrt J., Thyssen J.P., Melbye M. Filaggrin genotype and skin diseases independent of atopic dermatitis in childhood // Pediatr. Allergy Immunol. 2016. Vol. 27. N. 2. P. 162–168.
Bieber T. Atopic dermatitis // N. Engl. J. Med. 2008. Vol. 358. P. 1483–1494.
Bieber Th. Atopic dermatitis // Ann. Dermatol. 2010. Vol. 22. P. 125–137.
Bieber Th. Atopic dermatitis 2.0: from the clinical phenotype to the molecular taxonomy and stratified medicine // Allergy. 2012. Vol. 67. P. 1475–1482.
Brown S.J., Kroboth K., Sandilands A. et al. Intragenic copy number variation within filaggrin contributes to the risk of atopic dermatitis with a dose-dependent effect // J. Invest. Dermatol. 2012. Vol. 132. N. 1. P. 98–104.
Buchwald P., Bodor N. Soft glucocorticoid design: Structural elements and physicochemical parameters determining receptor-binding affinity // Pharmazie. 2004. Vol. 59. N. 5. P. 396–404.
Chavanas S., Bodemer C., Rochat A. et al. Mutations in SPINK5, encoding a serine protease inhibitor, cause Netherton syndrome // Nat. Genet. 2000. Vol. 25. N. 2. P. 141–142.
Danso M.O., van Drongelen V., Mulder A. et al. TNF-α and Th2 cytokines induce atopic dermatitis-like features on epidermal differentiation proteins and stratum corneum lipids in human skin equivalents // J. Invest. Dermatol. 2014. Vol. 134. N. 7. P. 1941–1950.
Deleuran M., Hvid M., Kemp K. et al. IL-25 induces both inflammation and skin barrier dysfunction in atopic dermatitis // Chem. Immunol. Allergy. 2012. Vol. 96. P. 45–49.
Deraison C., Bonnart C., Lopez F. et al. LEKTI fragments specifically inhibit KLK5, KLK7, and KLK14 and control desquamation through a pH-dependent interaction // Mol. Biol. Cell. 2007. Vol. 18. N. 9. P. 3607–3619.
Egawa G., Kabashima K. Multifactorial skin barrier deficiency and atopic dermatitis: Essential topics to prevent the atopic march // J. Allergy Clin. Immunol. 2016. Vol. 138. P. 350–358.
Eichenfield L.F., Call R.S., Forsha D.W. et al. Long-term safety of crisaborole ointment 2% in children and adults with mild to moderate atopic dermatitis // J. Am. Acad. Dermatol. 2017. Vol. 77. N. 4. P. 641–649.
Eichenfield L.F., Tom W.L., Berger T.G. et al. Guidelines of care for the management of atopic dermatitis, section 1: diagnosis and assessment of atopic dermatitis // J. Am. Acad. Dermatol. 2014. Vol. 70. N. 2. P. 338–351.
Eichenfield L.F., Tom W.L., Berger T.G. et al. Guidelines of care for the management of atopic dermatitis, section 2: management and treatment of atopic dermatitis with topical therapies // J. Am. Acad. Dermatol. 2014. Vol. 71. N. 1. P. 116–132.
Elias M.S., Long H.A., Newman C.F. et al. Proteomic analysis of filaggrin deficiency identifies molecular signatures characteristic of atopic eczema // J. Allergy Clin. Immunol. 2017. Vol. 140. N. 5. P. 1299–1309.
European Guideline (EuroGuiDerm) on atopic eczema — part II: non-systemic treatments and treatment recommendations for special AE patient populations // J. Eur. Acad. Dermatol. Venereol. 2022. Vol. 36. N. 11. P. 1904–1926. DOI: https://doi.org/10.1111/jdv.18429. Epub 2022 Sep 3.